PUBLIC CONTRACT · 2024
Medicamentos usados no tratamento das doenças endócrinas e hormonas
- Contract value
- €1,743.09
- Signed on
- 4 March 2024
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11079686PUBLISHED DESCRIPTION
13000000212024
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Lisboa, Loures
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- HIKMA FARMACÊUTICA (PORTUGAL) SA. · Tax ID 502266791
- Bidder
- Pharmis Biofarmacêutica, Lda. · Tax ID 502595442
- Bidder
- BDR · Tax ID 513077332
- Bidder
- Novo Nordisk Portugal, Lda. · Tax ID 501485210
- Bidder
- GENERIS - FARMACEUTICA, S.A. · Tax ID 508107997
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €1,743.09
- Procedure base price
- €8,618.08
- Total effective price
- Not reported on Portal BASE
- Publication date
- 11 December 2024
- Award date
- 4 March 2024
- Signing date
- 4 March 2024
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- CP 2021/47 - Medicamentos do aparelho locomotor, usados no tratamento das doenças endócrinas e hormonas
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 6869232
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.